Page last updated: 2024-11-07

prednisone and Cancer of the Urinary Tract

prednisone has been researched along with Cancer of the Urinary Tract in 3 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garje, R1
Chau, JJ1
Chung, J1
Wanat, K1
Zakharia, Y1
Kyriazoglou, A1
Liontos, M1
Papadopoulos, C1
Bilali, A1
Kostouros, E1
Pagoni, S1
Doumas, K1
Dimopoulos, MA1
Bamias, A1
Sekine, H1
Fukui, I1
Yamada, T1
Takeuchi, S1
Tachibana, Y1
Yokokawa, M1

Other Studies

3 other studies available for prednisone and Cancer of the Urinary Tract

ArticleYear
Acute Flare of Bullous Pemphigus With Pembrolizumab Used for Treatment of Metastatic Urothelial Cancer.
    Journal of immunotherapy (Hagerstown, Md. : 1997), 2018, Volume: 41, Issue:1

    Topics: Acute Disease; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Disease Prog

2018
Guillain-Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Review of the Literature.
    Clinical genitourinary cancer, 2019, Volume: 17, Issue:2

    Topics: Aged; Carcinoma, Transitional Cell; Fatal Outcome; Guillain-Barre Syndrome; Humans; Immunoglobulins,

2019
[Combination chemotherapy with bleomycin, vinca alkaloid and cisplatin (BVP) for advanced urothelial cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1984, Volume: 30, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Drug

1984